Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121347755 | 12134775 | 5 | F | 20160115 | 20160825 | 20160301 | 20160901 | EXP | US-BIOGEN-2016BI00194618 | BIOGEN | 66.12 | YR | F | Y | 0.00000 | 20160901 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121347755 | 12134775 | 1 | PS | TYSABRI | NATALIZUMAB | 1 | Intravenous (not otherwise specified) | 125104 | 300 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | ||||||||
| 121347755 | 12134775 | 2 | SS | TYSABRI | NATALIZUMAB | 1 | Intravenous (not otherwise specified) | INFUSED OVER 1 HOUR | 125104 | 300 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||
| 121347755 | 12134775 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | TABLETS | QD | |||||||
| 121347755 | 12134775 | 4 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 1/2 TABLET TWICE PER DAY | 0 | 10 | MG | TABLETS | |||||||
| 121347755 | 12134775 | 5 | C | CRANBERRY. | CRANBERRY | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 121347755 | 12134775 | 6 | C | cyclobenzapine | 2 | Oral | 0 | 10 | MG | TABLETS | BID | ||||||||
| 121347755 | 12134775 | 7 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 30 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||||
| 121347755 | 12134775 | 8 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 60 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||||
| 121347755 | 12134775 | 9 | C | GARLIC. | GARLIC | 1 | Oral | 0 | CAPSULE | QD | |||||||||
| 121347755 | 12134775 | 10 | C | herba vision | 2 | Unknown | 0 | UNKNOWN | |||||||||||
| 121347755 | 12134775 | 11 | C | oxycodone-acetaminophen | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 0 | 325 | MG | TABLETS | Q3H | |||||||
| 121347755 | 12134775 | 12 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | Oral | 0 | 50 | MG | CAPSULE | QD | |||||||
| 121347755 | 12134775 | 13 | C | TIZANIDINE. | TIZANIDINE | 1 | Oral | 0 | 4 | MG | TABLETS | BID | |||||||
| 121347755 | 12134775 | 14 | C | TRIMETHOPRIM. | TRIMETHOPRIM | 1 | Oral | 0 | 100 | MG | TABLETS | QD | |||||||
| 121347755 | 12134775 | 15 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 0 | 2000 | IU | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121347755 | 12134775 | 1 | Multiple sclerosis |
| 121347755 | 12134775 | 3 | Product used for unknown indication |
| 121347755 | 12134775 | 4 | Product used for unknown indication |
| 121347755 | 12134775 | 5 | Product used for unknown indication |
| 121347755 | 12134775 | 6 | Product used for unknown indication |
| 121347755 | 12134775 | 7 | Neuropathy peripheral |
| 121347755 | 12134775 | 9 | Product used for unknown indication |
| 121347755 | 12134775 | 10 | Product used for unknown indication |
| 121347755 | 12134775 | 11 | Pain |
| 121347755 | 12134775 | 12 | Product used for unknown indication |
| 121347755 | 12134775 | 13 | Product used for unknown indication |
| 121347755 | 12134775 | 14 | Product used for unknown indication |
| 121347755 | 12134775 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121347755 | 12134775 | DE |
| 121347755 | 12134775 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121347755 | 12134775 | Death | |
| 121347755 | 12134775 | Drug ineffective | |
| 121347755 | 12134775 | End stage renal disease | |
| 121347755 | 12134775 | Hip fracture | |
| 121347755 | 12134775 | Progressive relapsing multiple sclerosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121347755 | 12134775 | 1 | 20150921 | 20160208 | 0 |